Senate Democrats are warning Republican leadership that the health care bill moving through Congress would have disastrous consequences for the nation’s opioid epidemic, again putting the issue at the center of the debate on Capitol Hill.
Covenant Health bends its own cost curve with analytics in population health program | Healthcare IT News
Covenant Health Systems adopted a population health program to track and manage the health of its employees across three hospitals and affiliated facilities. Operating as a self-insured entity, Covenant saw this move as a necessity to improve health and get a grip on increasing expenses.
Two key geographic clusters dominate the biotech landscape today. These two areas, Boston and San Francisco, combine a unique blend of biomedical science, venture capital, entrepreneurial talent, risk-taking culture and geographic density.
HHS again delays enforcing 340B drug program | Healthcare Finance
The U.S. Department of Health and Human Services has again delayed the effective date of enforcing the final rule for the 340B drug pricing program to May 22, and may delay it further to Oct. 1.